EFFECTS OF ANGIOPEPTIN ON TRANSPLANT ARTERIOSCLEROSIS IN THE RAT

被引:5
作者
AKYUREK, ML
WANDERS, A
AURIVILLIUS, M
LARSSON, E
FUNA, K
FELLSTROM, BC
机构
[1] Department of Pathology, University Hospital, Uppsala
[2] Department of Medicine, University Hospital, Uppsala
[3] Ludwig Institute for Cancer Research, Biomedical Centre, Uppsala, S-751 24
关键词
ARTERIOSCLEROSIS; ANGIOPEPTIN; RAT; AORTA TRANSPLANTATION;
D O I
10.1007/BF00344419
中图分类号
R61 [外科手术学];
学科分类号
摘要
The influence of the somatostatin analogue angiopeptin on transplant arteriosclerosis was investigated using two aortic transplantation rat models. One was characterized by ischemia/reperfusion-induced changes in syngeneic transplants while immunologically induced changes dominated in the other allogeneic model. Angiopeptin, 100 mu g/kg per day, was administered continuously until the sacrifice of the rats after 8 weeks. No. additional immunosuppression was used in either model. An image analysis system was used to quantify the intimal and medial thicknesses of the grafts. In the syngeneic grafts, the intimal thickness was less than 50 % of that of control grafts (P < 0.05), but no difference was seen in the allogeneic model. The expression of selected cells, TGF-beta s, and PDGF and PDGF alpha-receptors was detected immunohistochemically and displayed a similar picture in control and angiopeptin-treated grafts in both models. We conclude that angiopeptin has no clear immunosuppressive properties but may counteract ischemia-induced transplant arteriosclerosis.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 40 条
[31]  
Scicchitano R., Stanisz A.M., Payan D.G., Kiyono H., McGee J.R., Bienestock J., Expression of substance P and somatostatin receptors on a T helper cell line, Adv Exp Med Biol, 216 A, pp. 185-190, (1987)
[32]  
Shiraishi T., Morimoto S., Ikoh K., Sato H., Sugihara K., Onisi T., Ogihara T., Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody towards a synthetic 73–79 fragment of its B-chain, Clin Chim Acta, 184, pp. 65-74, (1989)
[33]  
Stiko-Rahm A., Hultgard-Nilsson A., Regnstrom J., Haten A., Nilsson J., Oxidised and native LDL enhances production of PDGF-AA and the surface expression of PDGF receptors in cultured human arterial smooth muscle cells, Arterioscler Thromb, 12, pp. 1099-1109, (1992)
[34]  
Taylor J.E., Bodgen A.E., Moreau J.P., Coy D.H., In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue, Biochem Biophys Res Commun, 153, pp. 81-86, (1988)
[35]  
Taylor J.E., Moreau J.P., Baptiste L., Moody T.W., Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells, Peptides, 12, pp. 839-843, (1991)
[36]  
Vargas R., Bormes G.W., Wroblewska B., Foegh M.L., Kot P.A., Ramwell P.W., Angiopeptin inhibits thymidine incorporation in rat carotid artery in vivo, Transplant Proc, 21, pp. 3702-3704, (1989)
[37]  
Waltenberger J., Wanders A., Fellstrom B., Miyazono K., Heldin C.H., Funa K., Induction of transforming growth factor-β during cardiac allograft rejection, J Immunol, 151, pp. 1147-1157, (1993)
[38]  
Wanders A., Akyurek M.L., Waltenberger J., Stafberg C., Larsson E., Zhiping R., Funa K., Fellstrom B., The impact of ischemia time on chronic vascular rejection in the rat — effects of angiopeptin, Transplant Proc, 21, pp. 2098-2099, (1993)
[39]  
Willia A.F., Analysis of cell surfaces by xenogeneic mylemo-hybrid antibodies: differentiation antigens of rat lymphocytes, Cell, 12, pp. 663-673, (1977)
[40]  
Yilmaz S., Paavonen T., Hayry P., Chronic rejection of rat renal allografts, Transplantation, 53, pp. 823-827, (1992)